Theranos smacked down again, accuracy of tests fails to match major competitors - Seeking Alpha

Theranos smacked down again, accuracy of tests fails to match major competitors Seeking Alpha The results generated by LH and DGX were from samples obtained via traditional needle-based phlebotomy. The results of the study showed Theranos' test results were 160% more likely to be abnormal. The specific analyte cited was cholesterol, which ... and more »

from phlebotomy - Google News http://bit.ly/1qcbSAo